Es ist ein Fehler in der Kommunikation mit einem externen System aufgetreten. Bitte versuchen Sie Ihre letzte Aktion erneut. Sollte der Fehler bestehen bleiben, setzen Sie sich bitte mit dem Informationszentrum der Bibliothek in Verbindung oder versuchen Sie es später erneut.
The New England journal of medicine, 2022-08, Vol.387 (7), p.599-610
- Bramante, Carolyn T.
- Huling, Jared D.
- Tignanelli, Christopher J.
- Buse, John B.
- Liebovitz, David M.
- Nicklas, Jacinda M.
- Cohen, Kenneth
- Puskarich, Michael A.
- Belani, Hrishikesh K.
- Proper, Jennifer L.
- Siegel, Lianne K.
- Klatt, Nichole R.
- Odde, David J.
- Luke, Darlette G.
- Anderson, Blake
- Karger, Amy B.
- Ingraham, Nicholas E.
- Hartman, Katrina M.
- Rao, Via
- Hagen, Aubrey A.
- Patel, Barkha
- Fenno, Sarah L.
- Avula, Nandini
- Reddy, Neha V.
- Erickson, Spencer M.
- Lindberg, Sarah
- Fricton, Regina
- Lee, Samuel
- Zaman, Adnin
- Saveraid, Hanna G.
- Tordsen, Walker J.
- Pullen, Matthew F.
- Biros, Michelle
- Sherwood, Nancy E.
- Thompson, Jennifer L.
- Boulware, David R.
- Murray, Thomas A.
2022
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Bramante, Carolyn T.
- Huling, Jared D.
- Tignanelli, Christopher J.
- Buse, John B.
- Liebovitz, David M.
- Nicklas, Jacinda M.
- Cohen, Kenneth
- Puskarich, Michael A.
- Belani, Hrishikesh K.
- Proper, Jennifer L.
- Siegel, Lianne K.
- Klatt, Nichole R.
- Odde, David J.
- Luke, Darlette G.
- Anderson, Blake
- Karger, Amy B.
- Ingraham, Nicholas E.
- Hartman, Katrina M.
- Rao, Via
- Hagen, Aubrey A.
- Patel, Barkha
- Fenno, Sarah L.
- Avula, Nandini
- Reddy, Neha V.
- Erickson, Spencer M.
- Lindberg, Sarah
- Fricton, Regina
- Lee, Samuel
- Zaman, Adnin
- Saveraid, Hanna G.
- Tordsen, Walker J.
- Pullen, Matthew F.
- Biros, Michelle
- Sherwood, Nancy E.
- Thompson, Jennifer L.
- Boulware, David R.
- Murray, Thomas A.
- Titel
- Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
- Ist Teil von
- The New England journal of medicine, 2022-08, Vol.387 (7), p.599-610
- Ort / Verlag
- United States: Massachusetts Medical Society
- Erscheinungsjahr
- 2022
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0028-4793, 1533-4406eISSN: 1533-4406DOI: 10.1056/NEJMoa2201662Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9945922
- Format
- –
- Schlagworte
- Adult, Aged, Aged, 80 and over, Antidiabetics, Body weight, Charitable foundations, Coronavirus, Coronaviruses, COVID-19, COVID-19 - complications, COVID-19 Drug Treatment, COVID-19 Vaccines, Cytokines, Death, Double-Blind Method, Drug development, Drug dosages, Emergency medical care, Female, Fluvoxamine, Fluvoxamine - therapeutic use, Global Health, Humans, Hypoxemia, Hypoxia - etiology, Infections, Infectious Disease, Infectious Disease General, Investigations, Ivermectin, Ivermectin - therapeutic use, Male, Metformin, Metformin - therapeutic use, Middle Aged, Obesity - complications, Overweight, Overweight - complications, Oxygen saturation, Patients, Pregnancy, Pregnancy Complications, Infectious - drug therapy, SARS-CoV-2, Severe acute respiratory syndrome coronavirus 2, Statistical analysis, Vaccination, Viral Infections